Pharmaceuticals in Asia-Pacific

Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Asia-Pacific pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

– The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates.

– The Asia-Pacific pharmaceuticals market had total revenues of $276.4bn in 2016, representing a compound annual growth rate (CAGR) of 6.4% between 2012 and 2016.

– The regional market is dominated by the Chinese, which is also proving to be a major growth area due to rising incomes and a greater emphasis placed on healthcare. However, the Chinese market is quite fragmented, making it more attractive to foreign and domestic companies to consolidate through merger and acquisition.

– Although certain markets such as China, India and Indonesia are growing at a fast pace, more mature markets such as South Korea and Japan are not. Governments are keen to keep costs down as the healthcare demands from an aging population grow. Greater emphasis is being placed on generic drugs and pharmaceutical companies are under public pressure to provide cost effective drugs.

Scope

– Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Asia-Pacific

– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific

– Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

– Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Asia-Pacific pharmaceuticals market by value in 2016?

- What will be the size of the Asia-Pacific pharmaceuticals market in 2021?

- What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Asia-Pacific's pharmaceuticals market?

Companies mentioned

Daiichi Sankyo Co., Ltd.

Shanghai Pharmaceuticals Holding Co Ltd

Takeda Pharmaceutical Company Limited

Yangtze River Pharmaceutical Group

Table of Contents